Physician profile
Stephen Thomas Bernard
NPI 1306896246
$2,769.77
in general payments reported to CMS, 2019-2025
17 companies · $487 in 2025
The $487 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $109 · 2021: $905 · 2022: $436 · 2023: $261 · 2024: $433 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $687.20 | 2021-2022 | |
| Abiomed | $657.79 | 2021-2025 | Impella |
| Bard Peripheral Vascular, INC. | $279.35 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $273.28 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $201.42 | 2021-2024 | |
| Abbott Laboratories | $113.06 | 2023-2025 | Esprit, Diamondback Coronary, Coroflow |
| Shockwave Medical, INC | $97.65 | 2025 | |
| Boston Scientific Corporation | $84.06 | 2019-2021 | |
| Cardiovascular Systems INC. | $74.58 | 2021-2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $50.88 | 2019-2021 | |
| Amgen INC. | $48.15 | 2022-2023 | Repatha |
| Philips North America LLC | $47.35 | 2023-2024 | (5091) Amb Mon & Diag Und |
| Merck Sharp & Dohme LLC | $43.40 | 2022 | |
| Ekos Corporation | $41.39 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.24 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.04 | 2023 | |
| Chiesi USA, INC. | $13.93 | 2023 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.